Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.27 INR | +4.61% |
|
-.--% | -.--% |
Valuation
Fiscal Period: Marzo | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Capitalization 1 | 15.45 | 13.3 | 13.16 | 15.8 | 15.8 | 15.8 |
Enterprise Value (EV) 1 | 9.504 | 7.194 | 7.174 | 9.812 | 9.857 | 24.06 |
P/E ratio | -5.26 x | -4.95 x | -48.1 x | 47.9 x | -6.95 x | -3.1 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | - | - | - | - | - | - |
EV / Revenue | - | - | - | - | - | - |
EV / EBITDA | -3.01 x | -2.17 x | -2.92 x | -2.5 x | -2.08 x | -4.19 x |
EV / FCF | 0.11 x | 27.6 x | -3.33 x | -3.31 x | -12.8 x | 6.52 x |
FCF Yield | 908% | 3.62% | -30% | -30.2% | -7.83% | 15.3% |
Price to Book | 0.28 x | 0.26 x | 0.26 x | 0.31 x | 0.32 x | 0.36 x |
Nbr of stocks (in thousands) | 6,961 | 6,961 | 6,961 | 6,961 | 6,961 | 6,961 |
Reference price 2 | 2.220 | 1.910 | 1.890 | 2.270 | 2.270 | 2.270 |
Announcement Date | 10/24/19 | 1/21/22 | 1/21/22 | 11/30/22 | 5/29/23 | 6/15/24 |
Income Statement Evolution (Annual data)
Fiscal Period: Marzo | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales | - | - | - | - | - | - |
EBITDA 1 | -3.16 | -3.316 | -2.458 | -3.92 | -4.742 | -5.745 |
EBIT 1 | -3.46 | -3.612 | -2.753 | -4.22 | -5.038 | -6.025 |
Operating Margin | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -2.94 | -2.689 | -0.2735 | 0.33 | -2.273 | -5.098 |
Net income 1 | -2.94 | -2.689 | -0.2735 | 0.33 | -2.273 | -5.098 |
Net margin | - | - | - | - | - | - |
EPS 2 | -0.4223 | -0.3862 | -0.0393 | 0.0474 | -0.3265 | -0.7324 |
Free Cash Flow 1 | 86.26 | 0.2607 | -2.152 | -2.968 | -0.7718 | 3.687 |
FCF margin | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 10/24/19 | 1/21/22 | 1/21/22 | 11/30/22 | 5/29/23 | 6/15/24 |
Balance Sheet Analysis
Fiscal Period: Marzo | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | 8.25 |
Net Cash position 1 | 5.95 | 6.1 | 5.98 | 5.99 | 5.95 | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | -1.437 x |
Free Cash Flow 1 | 86.3 | 0.26 | -2.15 | -2.97 | -0.77 | 3.69 |
ROE (net income / shareholders' equity) | -2.93% | -5.08% | -0.53% | 0.64% | -4.5% | -10.9% |
ROA (Net income/ Total Assets) | -1.74% | -2.9% | -2.22% | -3.36% | -3.94% | -5.08% |
Assets 1 | 169.2 | 92.67 | 12.3 | -9.825 | 57.63 | 100.3 |
Book Value Per Share 2 | 7.800 | 7.420 | 7.380 | 7.430 | 7.100 | 6.370 |
Cash Flow per Share 2 | 0.8500 | 0.8800 | 0.8800 | 0.8700 | 0.8700 | 0.0100 |
Capex | - | - | - | 0.07 | - | 5.42 |
Capex / Sales | - | - | - | - | - | - |
Announcement Date | 10/24/19 | 1/21/22 | 1/21/22 | 11/30/22 | 5/29/23 | 6/15/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- MSCTC Stock
- Financials Mardia Samyoung Capillary Tubes Company Limited